13F HOLDINGS REPORT
GILEAD SCIENCES, INC.
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001123292-25-000364
Total Value
$1.28B
Positions
14
Other Managers
1
Confidential Omitted
No
Holdings (14)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | GALAPAGOS NV | GLPGF | 16,707,477 | $467.6M | 36.53% |
| 2 | ARCELLX INC | ACLX | 6,720,803 | $442.6M | 34.57% |
| 3 | ARCUS BIOSCIENCES INC | RCUS | 31,424,760 | $255.8M | 19.98% |
| 4 | ASSEMBLY BIOSCIENCES INC | ASMB | 2,209,471 | $40.0M | 3.13% |
| 5 | TANGO THERAPEUTICS INC | TNGX | 4,854,443 | $24.9M | 1.94% |
| 6 | MERUS N V | N5749R100 | 452,527 | $23.8M | 1.86% |
| 7 | KYVERNA THERAPEUTICS INC | KYTX | 4,126,119 | $12.7M | 0.99% |
| 8 | XILIO THERAPEUTICS INC | XLO | 9,105,451 | $6.2M | 0.48% |
| 9 | HOOKIPA PHARMA INC | HOOK | 1,875,945 | $2.4M | 0.18% |
| 10 | LEAP THERAPEUTICS INC | CYPH | 5,319,148 | $1.6M | 0.12% |
| 11 | ALLOGENE THERAPEUTICS INC | ALLO | 1,156,689 | $1.3M | 0.10% |
| 12 | KALARIS THERAPEUTICS INC | KLRS | 317,789 | $848,497 | 0.07% |
| 13 | IKENA ONCOLOGY INC | 45175G108 | 348,534 | $467,053 | 0.04% |
| 14 | BARINTHUS BIOTHERAPEUTICS PL | BRNS | 99,478 | $92,524 | 0.01% |